ConductScience.org, home

Paper235013

Tardive dyskinesia treated with pimozide.

Claveria LE and 6 others. J Neurol Sci, 1975. Cited by 46 papers, by iCite.

Cite this record

ConductScience Library. Tardive dyskinesia treated with pimozide. Papers, record 235013. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/235013

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tardive dyskinesia treated with pimozide.
PubMed
Journal
J Neurol Sci
PubMed
Year
1975
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
46
iCite
Relative citation ratio, by iCite
2.63
iCite
Revised in PubMed
2019-07-24
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Claveria LEL E
2Teychenne PFP F
3Calne DBD B
4Haskayne LL
5Petrie AA
6Pallis CAC A
7Lodge-Patch ICI C

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Movement DisordersMajor topic
PimozideMajor topic
Aged
Antipsychotic Agents
Bipolar Disorder
Chlorpromazine
Clinical Trials as Topic
Consciousness Disorders
Drug Therapy, Combination
Female
Fluphenazine
Humans
Male
Middle Aged
Parkinson Disease, Secondary
Perphenazine
Phenothiazines
Prochlorperazine
Promazine
Promethazine
Schizophrenia
Thioridazine

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.

PMIDTitleJournalYearIn PapersSource
29790082Chronic Administration of Pimozide Fails to Attenuate Motor and Pathological Deficits in Two Mouse Models of Amyotrophic Lateral Sclerosis.Neurotherapeutics2018https://conductscience.org/library/papers/29790082PubMed
29409162Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29409162PubMed
27885664Haloperidol plus promethazine for psychosis-induced aggression.Cochrane Database Syst Rev2016https://conductscience.org/library/papers/27885664PubMed
21847271Metoclopramide in tardive dyskinesia.Indian J Psychiatry1983https://conductscience.org/library/papers/21847271PubMed
17636691Thioridazine for schizophrenia.Cochrane Database Syst Rev2007https://conductscience.org/library/papers/17636691PubMed
17594079The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors.Psychopharmacology (Berl)2007https://conductscience.org/library/papers/17594079PubMed
17535043Conventional and atypical antipsychotics in the elderly : a review.Clin Drug Investig2003https://conductscience.org/library/papers/17535043PubMed
7373324Oxiperomide in tardive dyskinesia.J Neurol Neurosurg Psychiatry1980https://conductscience.org/library/papers/7373324PubMed
3998747Successful treatment of refractory Sydenham's chorea with pimozide.J Neurol Neurosurg Psychiatry1985https://conductscience.org/library/papers/3998747PubMed
3925489Effects of tiapride in tardive dyskinesia.Psychopharmacology (Berl)1985https://conductscience.org/library/papers/3925489PubMed
2895483Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia.Psychopharmacology (Berl)1988https://conductscience.org/library/papers/2895483PubMed
2880362
Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group.
Psychopharmacology (Berl)1986https://conductscience.org/library/papers/2880362PubMed
824116Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry.Drugs1976https://conductscience.org/library/papers/824116PubMed
417365Effect of baclofen on tardive dyskinesia.Psychopharmacology (Berl)1978https://conductscience.org/library/papers/417365PubMed
103110Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.Psychopharmacology (Berl)1978https://conductscience.org/library/papers/103110PubMed
44375Sulpiride in tardive dyskinesia.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/44375PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/235013

GET https://conductscience.org/api/papers/v1/235013/authors